ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,384Medicare Part D Prescriptions Filled, Including Refills

Rank: 970 out of 5176

$956K Total Retail Price of All Prescriptions

Rank: 293 out of 5176

368 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 7,739 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

53% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$114 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 331 331 1 15
AMLODIPINE BESYLATE 300 276 2 2
EVISTA 253 208 3 65
SIMVASTATIN 249 210 4 1
NEXIUM 226 208 5 16
ATORVASTATIN CALCIUM 167 147 6 9
ALENDRONATE SODIUM 162 145 7 18
LIDODERM 159 156 8 59
BENICAR 154 142 9 100
LOSARTAN POTASSIUM 137 103 10 14
METFORMIN HCL 136 122 11 7
DIOVAN 135 125 12 19
AZITHROMYCIN 134 119 13 42
LOVAZA 130 125 14 43
JANUVIA 122 110 15 25
FLUTICASONE PROPIONATE 111 99 16 38
TAMSULOSIN HCL 106 93 17 20
ZOLPIDEM TARTRATE 105 103 18 17
CELEBREX 103 101 19 80
PATANOL 101 101 20 158
AVODART 98 98 21 107
ALLOPURINOL 98 92 21 41
OMEPRAZOLE 96 87 23 3
PROMETHAZINE HCL 93 85 R 24 221
ACTOS 91 79 25 85
ATENOLOL 91 77 25 12
AMMONIUM LACTATE 91 91 25 91
CLOPIDOGREL 91 82 25 26
LEVOTHYROXINE SODIUM 89 83 29 4
PLAVIX 88 74 30 29
MECLIZINE HCL 86 80 31 81
ISOSORBIDE MONONITRATE ER 86 77 31 44
VOLTAREN 81 75 33 97
MICARDIS 77 76 34 154
ACTONEL 74 74 35 134
AMOXICILLIN 74 66 35 163
METOPROLOL SUCCINATE 73 72 37 11
BENICAR HCT 72 72 38 110
FINASTERIDE 71 71 39 69
FAMOTIDINE 70 60 40 58
PROAIR HFA 69 68 41 60
DONEPEZIL HCL 65 65 42 28
LIPITOR 63 56 43 51
MELOXICAM 62 61 44 53
BYSTOLIC 60 60 45 96
CLOBETASOL PROPIONATE 57 56 46 130
DIOVAN HCT 55 50 47 39
METOPROLOL TARTRATE 52 39 48 6
NIFEDIPINE ER 51 49 49 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.